SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF MOXALACTAM IN NORMAL SUBJECTS

被引：7

作者：

ISRAEL, KS

BLACK, HR

BRIER, GL

WOLNY, JD

DESANTE, KA

机构：

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1982年 / 22卷 / 01期

关键词：

D O I：

10.1128/AAC.22.1.94

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：94 / 102

页数：9

共 32 条

[1] INVITRO ACTIVITY OF LY127935 [J].

BARZA, M ;

TALLY, FP ;

JACOBUS, NV ;

GORBACH, SL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (03) :287-292

[2] PHARMACOKINETICS OF MOXALACTAM IN SUBJECTS WITH VARIOUS DEGREES OF RENAL DYSFUNCTION [J].

BOLTON, WK ;

SCHELD, WM ;

SPYKER, DA ;

OVERBY, TL ;

SANDE, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) :933-938

[3]

Brogard J M, 1978, Antibiot Chemother (1971), V25, P123

[4] DISULFIRAM-LIKE REACTION TO BETA-LACTAMS [J].

BUENING, MK ;

WOLD, JS ;

ISRAEL, KS ;

KAMMER, RB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (20) :2027-2028

[5] EFFECT OF PROBENECID ON THE PHARMACOKINETICS OF MOXALACTAM [J].

DESANTE, KA ;

ISRAEL, KS ;

BRIER, GL ;

WOLNY, JD ;

HATCHER, BL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :58-61

[6] CLINICAL-PHARMACOLOGY OF MOXALACTAM IN PATIENTS WITH MALIGNANT DISEASE [J].

ESTEY, EH ;

WEAVER, SS ;

HO, DHW ;

BODEY, GP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (04) :639-644

[7] INVITRO ACTIVITY OF LY127935 [J].

FASS, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (04) :503-509

[8]

FLUORNOY DJ, 1979, ANTIMICROB AGENTS CH, V16, P641

[9] PHARMACOKINETICS OF CEFOTAXIME [J].

FU, KP ;

ASWAPOKEE, P ;

HO, I ;

MATTHIJSSEN, C ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :592-597

[10]

HEWITT W, 1977, MICROBIOLOGICAL ASSA

← 1 2 3 4 →